Criteria for a Clinically Informative Serum Biomarker in Acute Ischaemic Stroke: A Review of S100B

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cerebrovascular Diseases

• Publication date

  2009-02-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000199468PMID 19202335
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MRI Detection of Early Blood-Brain Barrier Disruption: Parenchymal Enhancement Predicts Focal Hemorrhagic Transformation After Thrombolysis

  2008cited by this paper
• Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials

  2008cited by this paper
• Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials.

  2007cited by this paper
• Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke.

  2007influential reference
• Evidence for a wide extra-astrocytic distribution of S100B in human brain

  2007cited by this paper
• Association of Serial Biochemical Markers With Acute Ischemic Stroke: The National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study

  2006cited by this paper
• Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging

  2005cited by this paper
• The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study.

  2005cited by this paper
• Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction.

  2005cited by this paper
• Panel of Biomarkers Predicts Stroke

  2005cited by this paper
• Predicting functional outcome in acute stroke: comparison of a simple six variable model with other predictive systems and informal clinical prediction

  2004cited by this paper
• Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke.

  2004cited by this paper
• Serum S100B Predicts a Malignant Course of Infarction in Patients With Acute Middle Cerebral Artery Occlusion

  2004influential reference
• Comparison of MRI and CT for detection of acute intracerebral hemorrhage.

  2004cited by this paper
• Misdiagnosis of stroke in tissue plasminogen activator-treated patients: characteristics and outcomes.

  2003cited by this paper
• Early biomarkers of stroke.

  2003cited by this paper
• Novel Diagnostic Test for Acute Stroke

  2003cited by this paper
• Diagnostic Accuracy of Stroke Referrals From Primary Care, Emergency Room Physicians, and Ambulance Staff Using the Face Arm Speech Test

  2003cited by this paper
• S100B as a surrogate marker for successful clot lysis in hyperacute middle cerebral artery occlusion

  2003cited by this paper
• Serum S-100β as a possible marker of blood–brain barrier disruption

  2002cited by this paper
• Serum S-100beta as a possible marker of blood-brain barrier disruption.

  2002cited by this paper
• Predicting functional outcome and survival after acute ischemic stroke

  2002cited by this paper
• S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles.

  2001cited by this paper
• Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework

  2001cited by this paper
• Diagnosis of stroke with advanced CT and MR imaging.

  2000cited by this paper
• Comparison of serum S-100 protein levels following stroke and traumatic brain injury.

  2000cited by this paper
• Serial CT and MRI of ischaemic cerebral infarcts: frequency and clinical impact of haemorrhagic transformation

  2000cited by this paper
• Release of Glial Tissue–Specific Proteins After Acute Stroke: A Comparative Analysis of Serum Concentrations of Protein S-100B and Glial Fibrillary Acidic Protein

  2000cited by this paper
• Prediction of Malignant Middle Cerebral Artery Infarction by Diffusion-Weighted Imaging

  2000cited by this paper
• Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European cooperative acute stroke study (ECASS) I.

  1999cited by this paper
• Rapid ambulance protocol for acute stroke.

  1999cited by this paper
• Jugular venous and arterial concentrations of serum S-100B protein in patients with severe head injury: a pilot study

  1998cited by this paper
• Is visible infarction on computed tomography associated with an adverse prognosis in acute ischemic stroke?

  1998cited by this paper
• Is visible infarction on computed tomography associated with an adverse prognosis in acute ischemic stroke?

  1998cited by this paper
• Serum S-100 Protein, Relationship to Clinical Outcome in Acute Stroke

  1997cited by this paper
• S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction.

  1997cited by this paper
• Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke.

  1997cited by this paper
• S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke.

  1997cited by this paper
• Progressing neurological deficit secondary to acute ischemic stroke. A study on predictability, pathogenesis, and prognosis.

  1995cited by this paper
• S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system.

  1987cited by this paper
• Determination of three enolase isozymes and S-100 protein in various tumors in children.

  1983cited by this paper
• Temporal profile of neuronal damage in a model of transient forebrain ischemia

  1982cited by this paper
• A soluble protein characteristic of the nervous system.

  1965cited by this paper

• Ischemic stroke neuroprotection revisited: translational barriers and a phase-resolved, biomarker-anchored framework

  2026cites this paper
• Subphenotyping aneurysmal subarachnoid Hemorrhage using clinical and biological data clustering.

  2025cites this paper
• Implementing Blood Biomarkers in Stroke Research and Clinical Practice.

  2025cites this paper
• Upconversion nanoparticle-based optical biosensor for early diagnosis of stroke.

  2025cites this paper
• Association between three-dimensional high-resolution MRI indicators and risk of vascular events in intracranial atherosclerotic disease patients

  2025cites this paper
• Neuromonitoring modalities predicting neurological impairment in pediatric congenital heart disease: a systematic review

  2024cites this paper
• Biomarkers and the outcomes of ischemic stroke

  2023cites this paper
• Double Blast Wave Primary Effect on Synaptic, Glymphatic, Myelin, Neuronal and Neurovascular Markers

  2023cites this paper
• Blood-brain barrier permeability and electroconvulsive therapy - a systematic review.

  2023cites this paper
• Mini review: Current status and perspective of S100B protein as a biomarker in daily clinical practice for diagnosis and prognosticating of clinical outcome in patients with neurological diseases with focus on acute brain injury

  2023cites this paper
• S100B, Actor and Biomarker of Mild Traumatic Brain Injury

  2023cites this paper
• Biomarkers In Hypertension And Hypertension-Related Disorders.

  2022cites this paper
• The effectiveness of serum S100B, TRAIL, and adropin levels in predicting clinical outcome, final infarct core, and stroke subtypes of acute ischemic stroke patients

  2022cites this paper
• Serum S-100B adds incremental value for the prediction of symptomatic intracranial hemorrhage and brain edema after acute ischemic stroke

  2022cites this paper
• AllergoOncology: Role of immune cells and immune proteins

  2022cites this paper
• Serum S100B protein after electroconvulsive therapy in patients with depression.

  2022cites this paper
• New Candidates for Biomarkers and Drug Targets of Ischemic Stroke—A First Dynamic LC-MS Human Serum Proteomic Study

  2022cites this paper
• Neurofilament Light Chain Protein Is a Predictive Biomarker for Stroke After Surgical Repair for Acute Type A Aortic Dissection

  2021cites this paper
• Study on collateral circulation level and prognosis of acute ischemic stroke by 4D CTA-CTP integrated technology and serum S100B.

  2021cites this paper
• Neuron-specific enolase level as a predictor of neurological outcome in near-hanging patients: A retrospective multicenter study.

  2021cites this paper
• Prediction of Outcome After Endovascular Embolectomy in Anterior Circulation Stroke Using Biomarkers

  2021cites this paper
• About IJMA

  2021cites this paper
• Serum Extracellular Vesicle–Derived miR-124-3p as a Diagnostic and Predictive Marker for Early-Stage Acute Ischemic Stroke

  2021cites this paper
• High serum S-100B protein levels within the first 36 hours of acute ischemic stroke predicts high NIHSS scores

  2020cites this paper
• Biomarkers Facilitate the Assessment of Prognosis in Critically Ill Patients with Primary Brain Injury: A Cohort Study

  2020cites this paper
• Diagnostic Value of Serum Biomarkers for Differentiating Central and Peripheral Causes of Acute Vertigo

  2020cites this paper
• Association of biomarker S100B and cerebral oximetry with neurological changes during carotid endarterectomy performed in awake patients.

  2020cites this paper
• Serum Levels of Soluble Triggering Receptor Expressed on Myeloid Cells-1 Associated with the Severity and Outcome of Acute Ischemic Stroke

  2020cites this paper
• Serum S100β as a predictor of severity and outcomes for mixed subtype acute ischaemic stroke.

  2020influential citation
• Damage-associated molecular patterns in trauma

  2019cites this paper
• A Paper-Based Elisa Device for the Rapid Detection of Ischemic Stroke

  2019cites this paper
• Serum S 100 β as a predictor of severity and outcomes for mixed subtype acute ischaemic stroke

  2019influential citation
• A SERS-based lateral flow assay for the stroke biomarker S100-β

  2019cites this paper
• Danger signals in trauma

  2018cites this paper
• Sevoflurane reduces ischemic brain injury in rats with diet and streptozotocin-induced diabetes

  2018cites this paper
• Clinical Significance of Serum Biomarker S 100 B to Predict Outcome After Traumatic Brain Injury

  2017cites this paper
• The microRNA miR‐124 inhibits vascular smooth muscle cell proliferation by targeting S100 calcium‐binding protein A4 (S100A4)

  2017cites this paper
• HMGB1, IL-1alpha, IL-33 and S100 proteins: dual-function alarmins

  2017cites this paper
• Plasma thrombin-cleaved osteopontin as a potential biomarker of acute atherothrombotic ischemic stroke

  2017cites this paper
• New biomarker for acute ischaemic stroke: plasma glycogen phosphorylase isoenzyme BB

  2017cites this paper
• Prognostic value of somatosensory evoked potentials, neuron-specific enolase, and S100 for short-term outcome in ischemic stroke.

  2016cites this paper
• Diagnostic performance of peroxiredoxin 1 to determine time-of-onset of acute cerebral infarction

  2016cites this paper
• Serum neuron specific enolase could predict subclinical brain damage and the subsequent occurrence of brain related vascular events during follow up in essential hypertension.

  2016cites this paper
• Biomarker value and pitfalls of serum S100B in the follow‐up of high‐risk melanoma patients

  2016cites this paper
• HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins

  2016cites this paper
• Eignung und Probleme von Serum S100B als Biomarker zur Verlaufskontrolle bei Hochrisiko‐Melanompatienten

  2016cites this paper
• Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis

  2016cites this paper
• Peripheral blood markers of central nervous system effects following controlled human exposure to diesel exhaust

  2016cites this paper
• The Diagnostic Value of Circulating Brain-specific MicroRNAs for Ischemic Stroke.

  2016cites this paper
• Proenkefalin A and protachykinin in ischemic neurological complications after cardiac surgery.

  2016cites this paper
• Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke

  2016influential citation
• The determination of copeptin levels helps management decisions among transient ischaemic attack patients

  2016cites this paper
• Title Targeted lipid profiling discovers plasma biomarkers of acute brain injury

  2015cites this paper
• E-selectin and vascular cell adhesion molecule-1 as biomarkers of 3-month outcome in cerebrovascular diseases

  2015cites this paper
• Current and future bioanalytical approaches for stroke assessment.

  2015cites this paper
• Targeted Lipid Profiling Discovers Plasma Biomarkers of Acute Brain Injury

  2015cites this paper
• Can we distinguish stroke and stroke mimics via red cell distribution width in young patients?

  2015cites this paper
• Prognostic Value of Somatosensory Evoked Potentials, Neuron-specific 3 Enolase, and S 100 for Short Term Outcome in Ischemic Stroke 4 Prediction of Stroke Outcome by Sep, Nse and S100 7 8

  2015cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1089 Hyperglycemia in Experimental Cerebral Ischemia

  2015cites this paper
• Hyperglycemia in Experimental Cerebral Ischemia

  2015cites this paper
• Neuronal and Glia-Related Biomarkers in Cerebrospinal Fluid of Patients with Acute Ischemic Stroke

  2014cites this paper
• Avaliação temporal da expressão gênica e proteica de S100b no encéfalo de ratos neonatos submetidos à anóxia.

  2014cites this paper
• Assessment of S100β Biomarker in Acute Ischemic Cerebrovascular Stroke Patients with Hypertension

  2014cites this paper
• Biomarkers and acute brain injuries: interest and limits

  2014cites this paper
• S-100B Levels in Stroke Patients: Is It Useful for Showing Short-term Mortality?

  2014cites this paper
• Serum Protein S100β is a Diagnostic Biomarker for Distinguishing Posterior Circulation Stroke from Vertigo of Nonvascular Causes

  2014cites this paper
• Serum S100B Protein as an Outcome Prediction Tool in Emergency Department Patients with Traumatic Brain Injury

  2014cites this paper
• MARCADORES HEMOQUÍMICOS DE AFECTACIÓN AL TEJIDO NERVIOSO COMO INDICADORES DE DAÑO EN LA HIPERTENSIÓN ARTERIAL ESENCIAL Y EN EL ICTUS

  2013cites this paper
• RNA-based blood genomics as an investigative tool and prospective biomarker for ischemic stroke

  2013cites this paper
• Increased plasma agmatine levels in patients with schizophrenia.

  2013cites this paper
• Limited clinical value of multiple blood markers in the diagnosis of ischemic stroke.

  2013cites this paper
• S100B protein in serum is elevated after global cerebral ischemic injury.

  2013cites this paper
• N-methyl-D-aspartate-Receptor Antibodies, S100B Protein, and Neuron-Specific Enolase Before and After Cardiac Surgery: Association with Ischemic Brain Injury and Erythropoetin Prophylaxis

  2013cites this paper
• S100B protein in serum is elevated after global cerebral ischemic injury

  2013cites this paper
• Prognostic Value of Plasma Neuroendocrine Biomarkers in Patients with Acute Ischaemic Stroke

  2013cites this paper
• S100b Protein Levels in Subretinal Fluid in Rhegmatogenous Retinal Detachment

  2012cites this paper
• Brain Damage - Bridging Between Basic Research and Clinics

  2012cites this paper
• Demonstration of Subclinical Organ Damage to the Central Nervous System in Essential Hypertension

  2012cites this paper
• Blood–brain barrier dysfunction in brain diseases: Clinical experience

  2012cites this paper
• Short-term prognostic value of serum neuron specific enolase and S100B in acute stroke patients.

  2012cites this paper
• Clinical neuroproteomics and biomarkers: from basic research to clinical decision making.

  2012cites this paper
• Functions of S100 proteins.

  2012cites this paper
• Transcranial Doppler microembolic signals and serum marker evidence of brain injury during transcatheter aortic valve implantation

  2012cites this paper
• Serum neuron-specific enolase and S100 calcium binding protein B biomarker levels do not improve diagnosis of acute stroke

  2012cites this paper
• Serum biomarkers of neurologic injury in cardiac operations.

  2012cites this paper
• Infarctus cérébral et plasticité : focus sur le BDNF

  2011cites this paper
• The S100B Protein Could Be Used as Adjuvant Diagnostic Tool in Acute Ischemic Stroke

  2011cites this paper
• Novel serum proteomic signatures in a non-human primate model of retinal injury

  2011cites this paper
• Increased serum S-100B and neuron specific enolase - Potential markers of early nervous system involvement in essential hypertension.

  2011cites this paper
• Selection for inpatient rehabilitation after acute stroke: a systematic review of the literature.

  2011cites this paper
• Blood Biomarkers for the Diagnosis of Acute Cerebrovascular Diseases: A Prospective Cohort Study

  2011cites this paper
• Effect of Carotid Artery Stenting on the Release of S-100B and Neurone-Specific Enolase

  2011cites this paper
• Growth Differentiation Factor 15 Plasma Levels and Outcome after Ischemic Stroke

  2011cites this paper
• Hyperacute Detection of Neurofilament Heavy Chain in Serum Following Stroke: A Transient Sign

  2011cites this paper
• Blood markers for the diagnosis and prognosis of stroke

  2011cites this paper
• Correlation of Levels of Neuronal and Glial Markers with Radiological Measures of Infarct Volume in Ischaemic Stroke: A Systematic Review

  2011cites this paper
• Molecular markers and mechanisms of stroke: RNA studies of blood in animals and humans

  2011cites this paper
• The Temporal Profile of Inflammatory Markers and Mediators in Blood after Acute Ischemic Stroke Differs Depending on Stroke Outcome

  2010cites this paper
• Adipocytes as an Important Source of Serum S100B and Possible Roles of This Protein in Adipose Tissue

  2010cites this paper
• Cerebral effects of hyperglycemia in experimental cardiac arrest

  2010cites this paper